Cargando…
Improving Adherence to Topical Medication in Patients with Glaucoma
The glaucomas form a heterogenous group of conditions, which collectively account for one of the most common irreversible causes of blindness worldwide. The only treatment, for which there is evidence, to stop or slow glaucomatous disease progression is to lower intraocular pressure (IOP); this is m...
Autores principales: | Tapply, Ian, Broadway, David C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259615/ https://www.ncbi.nlm.nih.gov/pubmed/34239297 http://dx.doi.org/10.2147/PPA.S264926 |
Ejemplares similares
-
Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study)
por: Cate, Heidi, et al.
Publicado: (2014) -
Adherence to Topical Glaucoma Medications in Ethiopian Patients
por: Tamrat, Lemlem, et al.
Publicado: (2015) -
Improving adherence to guidelines for extended venous thromboembolism prophylaxis in patients with colorectal cancer
por: Patel, Markand, et al.
Publicado: (2013) -
The impacts of COVID-19 on glaucoma patient outcomes as assessed by POEM
por: Pujari, Rathin, et al.
Publicado: (2021) -
Intensity of side effects of topical glaucoma medication and its influence on adherence behavior in patients with glaucoma
por: Yu, Alice L, et al.
Publicado: (2014)